Clinical assessment of novel therapies is paramount in ensuring the future of beneficial heal
read More
Cyclotek’s product portfolio has been expanded by the addition of dopamine transporter radi
read More
Patients will no longer need to pay for these scans themselves and will have equitable access
read More
Applied Molecular Therapies (AMT) has announced a successful TGA licence upgrade for the GMP
read More
Cyclotek’s Media Associate Nicoletta Snellen recently sat down with Eden Carnegie, Quality
read More
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australiaâ
read More
[contact-form-7 id=”714″ title=”Update Form”]
